Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.72M Hold
96,750
0.65% 26
2025
Q4
$2.41M Buy
96,750
+7,200
+8% +$182K 0.58% 37
2025
Q3
$2.28M Buy
89,550
+8,000
+10% +$197K 0.52% 43
2025
Q2
$1.98M Hold
81,550
0.44% 40
2025
Q1
$2.07M Buy
+81,550
New +$2.13M 0.44% 41
2024
Q1
Sell
-123,025
Closed -$3.54M 92
2023
Q4
$3.54M Sell
123,025
-84,700
-41% -$2.56M 0.6% 38
2023
Q3
$6.89M Buy
207,725
+13,800
+7% +$488K 1.25% 16
2023
Q2
$7.11M Buy
193,925
+9,450
+5% +$368K 1.2% 15
2023
Q1
$7.53M Buy
184,475
+23,545
+15% +$1.02M 1.49% 15
2022
Q4
$8.25M Sell
160,930
-5,460
-3% -$262K 1.71% 12
2022
Q3
$7.28M Hold
166,390
1.61% 13
2022
Q2
$8.72M Sell
166,390
-30,000
-15% -$1.53M 1.51% 18
2022
Q1
$10.2M Sell
196,390
-193,185
-50% -$10M 1.6% 18
2021
Q4
$23M Sell
389,575
-140,000
-26% -$6.94M 3.37% 5
2021
Q3
$22.8M Hold
529,575
3.25% 6
2021
Q2
$20.7M Buy
529,575
+196,850
+59% +$7.66M 2.71% 9
2021
Q1
$12.1M Sell
332,725
-7,500
-2% -$266K 1.54% 17
2020
Q4
$12.5M Sell
340,225
-30,309
-8% -$1.11M 1.77% 15
2020
Q3
$12.9M Hold
370,534
2.11% 11
2020
Q2
$11.5M Buy
370,534
+42,635
+13% +$1.45M 2.01% 13
2020
Q1
$10.2M Hold
327,899
2.07% 10
2019
Q4
$12.2M Hold
327,899
1.86% 15
2019
Q3
$11.2M Sell
327,899
-13,702
-4% -$498K 1.84% 14
2019
Q2
$14M Sell
341,601
-26,350
-7% -$1.05M 2.24% 13
2019
Q1
$14.8M Sell
367,951
-107,103
-23% -$4.29M 2.3% 14
2018
Q4
$19.7M Sell
475,054
-387,302
-45% -$16.1M 3.15% 8
2018
Q3
$36.1M Sell
862,356
-393,248
-31% -$15.1M 5.41% 2
2018
Q2
$43.2M Sell
1,255,604
-7,072
-0.6% -$242K 6.46% 1
2018
Q1
$42.5M Sell
1,262,676
-150,090
-11% -$5.16M 6.79% 1
2017
Q4
$48.5M Sell
1,412,766
-316,200
-18% -$10.8M 8.02% 1
2017
Q3
$58.6M Sell
1,728,966
-115,119
-6% -$3.7M 9.72% 1
2017
Q2
$58.8M Hold
1,844,085
10.1% 1
2017
Q1
$59.9M Buy
1,844,085
+81,000
+5% +$2.55M 9.21% 2
2016
Q4
$54.3M Buy
1,763,085
+727,260
+70% +$22.2M 9.15% 2
2016
Q3
$33.3M Sell
1,035,825
-26,497
-2% -$886K 6.43% 2
2016
Q2
$35.5M Sell
1,062,322
-52,700
-5% -$1.68M 7.04% 1
2016
Q1
$31.4M Buy
1,115,022
+389,505
+54% +$11.1M 6% 4
2015
Q4
$22.2M Sell
725,517
-44,900
-6% -$1.41M 4.01% 5
2015
Q3
$23M Hold
770,417
3.95% 5
2015
Q2
$24.5M Sell
770,417
-140
-0% -$4.56K 3.96% 6
2015
Q1
$25.4M Buy
770,557
+166,005
+27% +$5.28M 4.11% 6
2014
Q4
$17.9M Hold
604,552
2.68% 12
2014
Q3
$17M Hold
604,552
2.71% 11
2014
Q2
$17M Hold
604,552
2.43% 13
2014
Q1
$18.4M Hold
604,552
2.77% 12
2013
Q4
$17.6M Hold
604,552
2.49% 10
2013
Q3
$16.5M Buy
604,552
+1,475
+0.2% +$40.1K 2.5% 11
2013
Q2
$16M Buy
+603,077
New +$16.7M 2.76% 7

Other funds holding PFE

Clark Estates Inc's PFE Position: Q1 2026 in Review

Clark Estates Inc held its Pfizer (PFE) position steady in Q1 2026 at 96,750 shares worth $2.72M. The position accounts for 0.65% of the portfolio, ranked #26.

Clark Estates Inc first reported a position in PFE in Q2 2013 and has held it in 48 quarters since. The position peaked at $59.9M in Q1 2017. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Clark Estates Inc held 96,750 shares of Pfizer worth $2.72M as of Q1 2026.
  • Clark Estates Inc left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.65% of Clark Estates Inc's portfolio in Q1 2026, its #26 holding.
  • Clark Estates Inc first reported a position in Pfizer in Q2 2013 and has held it in 48 quarters since.
  • Clark Estates Inc's Pfizer position peaked at $59.9M in Q1 2017.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Clark Estates Inc's 13F filing for Q1 2026, filed 11 May 2026.